1. Bruckert, E., Simonetta, C., & Giral, P. (1999). Compliancy with fluvastatin treatment characterization of the noncompliant population within a study population of 3845 patients with hyperlipidemia. CREOLE Study Team. Journal of Clinical Epidemiology, 52, 589–594.
2. Burrell, C. D., & Levy, R. A. (1984). Therapeutic consequences of noncompliance. Improving medication compliance. Proceedings of a symposium, (pp. 7–16). Washington, DC: National Pharmaceutical Council.
3. DiMatteo, M. R., Lepper, H. S., & Croghan, T. W. (2000). Depression is a risk factor for noncompliance with medical treatment: Meta-analysis of the effects of anxiety and depression on patient adherence. Archives of Internal Medicine, 160, 2101–2107.
4. Haynes, R. B., Ackloo, E., Sahota, N., McDonald, H. P., & Yao, X. (2001). Interventions for enhancing medication adherence. Cochrane Database of Systematic Review 2008, Issue 2. Art. No.: CD000011. DOI: 10.1002/14651858.CD000011.pub.3
5. National Pharmaceutical Council. (1992). Noncompliance with medication regimens: An economic tragedy. Emerging issues in pharmaceutical cost containing, (pp. 1–16). Washington, DC: National Pharmaceutical Council.